News

Margaret A. Hamburg, MD, Joins NTI as Interim Vice President for NTI | bio

NTI board member Margaret A. Hamburg, MD, is joining NTI’s leadership to serve as interim vice president of the NTI | bio program in February. Hamburg, an internationally recognized leader in public health and medicine, replaces Beth Cameron, PhD, who has moved to the White House to rebuild the National Security Council’s Office of Global Health Security and Biodefense and advance the Biden Administration’s agenda on global health security.

Hamburg’s relationship with NTI goes back to its launch in 2001, when she was named as the organization’s founding senior scientist and biological program vice president. She went on to become commissioner of the Food and Drug Administration and foreign secretary of the National Academy of Medicine.

Hamburg joined NTI’s Board of Directors in 2017.

Stay Informed

Sign up for our newsletter to get the latest on nuclear and biological threats.

Sign Up

More News

NTI Statement in Support of WHO Pandemic Accord
The NTI Logo

News

NTI Statement in Support of WHO Pandemic Accord

NTI applauds today’s announcement that the International Negotiating Body of the World Health Organization (WHO) has reached a deal on the language of the Pandemic Accord. Pandemics continue to pose a global threat, and this proposed agreement is proof that the world can unify to reduce the most catastrophic risks.


NTI | bio Recommends Prioritizing AIxBio Safeguards in New U.S. AI Action Plan

News

NTI | bio Recommends Prioritizing AIxBio Safeguards in New U.S. AI Action Plan

NTI | bio has responded to the U.S. government request for information (RFI) related to the Artificial Intelligence (AI) Action Plan outlined by President Donald Trump’s January 2025 Executive Order, providing input on the highest priority actions to maintain and extend U.S. global leadership on AI. 



See All News

Close

My Resources